Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kalow

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
Clinical Pharmacology and Therapeutics|April 1, 1980
Deficient metabolism of debrisoquine and sparteineT Inaba, S V Otton, W Kalow
Pharmacogenetics|February 1, 1992
Variability of acetaminophen metabolism in Caucasians and OrientalsM Patel, B K Tang, W Kalow
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1978
N-Demethylation of cocaine in the rat and in isolated rat hepatocytes: comparison with aminopyrine demethylationD J Stewart, T Inaba, W Kalow
Pharmacogenetics|February 1, 1993
Utilizing urinary metabolite data in studying the variability of acetaminophen metabolismM Patel, B K Tang, W Kalow
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1996
Correspondence re: S. H. McQuilkin et al., analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-Acetyltransferase-2 activities. Cancer Epidemiol., Biomarkers & Prev., 4: 139-146, 1995B K Tang, W Kalow, D Nierenberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1975
N-hydroxyamobarbital: the second major metabolite of amobarbital in manB K Tang, T Inaba, W Kalow
European Journal of Clinical Pharmacology|October 10, 1975
Comparative drug elimination in man-diphenylhydantoin and amobarbitalJ F Brien, T Inaba, W Kalow
Experientia|September 15, 1984
High affinity of quinidine for a stereoselective microsomal binding site as determined by a radioreceptor assayS V Otton, W Kalow, P Seeman
Pharmacogenetics|February 1, 1995
(S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7M Patel, B K Tang, W Kalow
Canadian Journal of Physiology and Pharmacology|April 1, 1983
Paraoxonase phenotype distribution in Canadian Indian and Inuit populationsG Carro-Ciampi, S Gray, W Kalow
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|April 1, 1980
Deficient metabolism of debrisoquine and sparteineT Inaba, S V Otton, W Kalow
Pharmacogenetics|February 1, 1992
Variability of acetaminophen metabolism in Caucasians and OrientalsM Patel, B K Tang, W Kalow
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1978
N-Demethylation of cocaine in the rat and in isolated rat hepatocytes: comparison with aminopyrine demethylationD J Stewart, T Inaba, W Kalow
Pharmacogenetics|February 1, 1993
Utilizing urinary metabolite data in studying the variability of acetaminophen metabolismM Patel, B K Tang, W Kalow
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1996
Correspondence re: S. H. McQuilkin et al., analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-Acetyltransferase-2 activities. Cancer Epidemiol., Biomarkers & Prev., 4: 139-146, 1995B K Tang, W Kalow, D Nierenberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1975
N-hydroxyamobarbital: the second major metabolite of amobarbital in manB K Tang, T Inaba, W Kalow
European Journal of Clinical Pharmacology|October 10, 1975
Comparative drug elimination in man-diphenylhydantoin and amobarbitalJ F Brien, T Inaba, W Kalow
Experientia|September 15, 1984
High affinity of quinidine for a stereoselective microsomal binding site as determined by a radioreceptor assayS V Otton, W Kalow, P Seeman
Pharmacogenetics|February 1, 1995
(S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7M Patel, B K Tang, W Kalow
Canadian Journal of Physiology and Pharmacology|April 1, 1983
Paraoxonase phenotype distribution in Canadian Indian and Inuit populationsG Carro-Ciampi, S Gray, W Kalow
Pageof 19